These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 9134169)
1. Autologous and allogeneic transplantation for multiple myeloma at a single centre. Couban S; Stewart AK; Loach D; Panzarella T; Meharchand J Bone Marrow Transplant; 1997 Apr; 19(8):783-9. PubMed ID: 9134169 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma. El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414 [TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476 [TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [TBL] [Abstract][Full Text] [Related]
8. Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma. Qazilbash MH; Saliba R; De Lima M; Hosing C; Couriel D; Aleman A; Roden L; Champlin R; Giralt SA Cancer; 2006 Mar; 106(5):1084-9. PubMed ID: 16456814 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688 [TBL] [Abstract][Full Text] [Related]
11. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968 [TBL] [Abstract][Full Text] [Related]
12. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J Bone Marrow Transplant; 1999 Oct; 24(7):741-5. PubMed ID: 10516677 [TBL] [Abstract][Full Text] [Related]
13. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937 [TBL] [Abstract][Full Text] [Related]
14. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson KC Bone Marrow Transplant; 2003 Dec; 32(12):1145-51. PubMed ID: 14647268 [TBL] [Abstract][Full Text] [Related]
15. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
16. Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience. Kennedy GA; Butler J; Morton J; Hill G; Western R; Cummings J; Allison R; Durrant S Clin Lab Haematol; 2006 Jun; 28(3):189-97. PubMed ID: 16706936 [TBL] [Abstract][Full Text] [Related]
17. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno NT; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R Bone Marrow Transplant; 2002 Sep; 30(6):367-73. PubMed ID: 12235521 [TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A; Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]